388619-64-5: Lacosamide N-Methyl Racemic Mixture (USP)
Lacosamide N-Methyl Impurity (CAS No: 388619-64-5) Or (R)-2-(Acetylamino)-3-methoxy-N-methyl-N-(phenylmethyl)-propanamide, Lacosamide N-Methyl Impurity is an impurity present in Lacosamide. Lacosamide is approved for anticonvulsive treatment in focal epilepsy, which exhibits its function through the slow inactivation of voltage-gated sodium channels, used in the treatment of partial-onset seizures.
Additional information on CAS 388619-64-5
VE009522
388619-64-5
C14H20N2O3
264.3 g/mol
Lacosamide
2-acetamido-N-benzyl-3-methoxy-N-methylpropanamide
N/A
Bauer, S., Willems, L. M., Paule, E., Petschow, C., Zöllner, J. P., Rosenow, F., & Strzelczyk, A. (2016). The efficacy of lacosamide as monotherapy and adjunctive therapy in focal epilepsy and its use in status epilepticus: clinical trial evidence and experience. Therapeutic Advances in Neurological Disorders, 10(2), 103–126. https://doi.org/10.1177/1756285616675777
In-stock
